PUBLICATIONS - Joseph David Rosenblatt, M.D.
Books and monographs published:
Santos, Edgardo S., Rosenblatt, Joseph D., Goodman, Mark. Role of Farnesyltransferase Inhibitors in Hematologic Malignancies. Future Drugs, Vol. 4, No. 5, October 2004, pp 843-856.
Lancet JE, Rosenblatt JD, Karp JE. Farnesyltransferase inhibitors and myeloid malignancies: Phase I evidence of ZARNESTRA activity in high-risk leukemias. Seminars in Hematology, Vol 39, No 3, Suppl 2, July 2002, pp 31-35.
Karp JE, Lancet JE, Wright J, Rosenblatt JD. Farnesyltransferase inhibition in Leukemias: Correlative Clinical-Laboratory Trials with Zarnestra (R11577). Blood-Immunity-Cancer , Vol 7, No. 1 67-72, 2002.
Coliccio F, Griggs, J, Rosenblatt J. Basic Concepts in Drug Development Clinical Trials. In: Clinical Oncology, 8th Edition, Ed: Phillip Rubin. WB Saunders Co, Philadelphia, 2001, 160-167.
Rubin, Williams, Okunieff, Rosenblatt, Sitzmann. Statement of the Clinical Oncologic Problem. In: Clinical Oncology, 8th Edition, Ed: Phillip Rubin. WB Saunders Co, Philadelphia, 2001, 1-31.
Tolba K, Federoff HJ, Rosenblatt JD. Gene Therapy for Cancer. In: Clinical Oncology, 8th Edition, Ed: Philip Rubin. WB Saunders Co, Philadelphia, 2001, 168-184.
Maurer C, Harrington WJ, Gill P, Kampe CE, Rosenblatt JD. Adult T-cell leukemia/lymphoma. In: Cancer Treatment, 5th Edition, Chapter 96, Ed: Haskell CM, WB Saunders Co, Philadelphia, PA., 2001, 1474-1486.
Khorana A, Rosenblatt J, Young F. Immunopathogenesis of HIV and HTLV-1 Infection: Mechanisms for Lymphomagenesis. In: Cancer Treatment and Research Series; HIV-Associated Malignancies. Ed: Joseph A. Sparano, M.D., Kluwer Academic Publishers, Norwell, MA., 2001, Chapter 2:19-74.
Kharuddin, JJ, Rosenblatt, JD. Type C oncoviruses-Human T-cell lymphotropic virus Types I and II. In: Principles and Practice of Infectious Diseases, 5th Edition, Volume 2. Eds: Mandell GL, Bennett, JE and Dolin, WB Saunders Co., Philadelphia, PA, 2000.
Mahmood, K, Tolba K, Federoff HJ, Rosenblatt JD. The role of HSV amplicon vectors in cancer gene therapy. In: Gene Therapy and Molecular Biology, Boulikas T (ed), December, 1999, 4:209-219.
Rimel BJ, Rosenblatt JD, Planelles V. HTLV-II. Encyclopedia of Virology, Second Edition, Granoff A, Webster RG (eds), Academic Press, San Diego, CA, June, 1999.
Klimatcheva E, Rosenblatt JD, Planelles V. Lentiviral vectors and Gene Therapy. Frontiers in Bioscience, June, 1999, 4:D481-96.
Newman CL, Rosenblatt JD. Human T-cell lymphotropic viruses. Chapter in Human Tumor Viruses. American Society of Microbiology Pres, McCance D., Editor, 1998, pp. 331-357.
Ifthikharuddin JJ, Rosenblatt JD. Introduction-Type C oncoviruses including human T-cell lymphotropic virus types I and II. In: Principles of Infectious Diseases, 5th Edition. GL Mandell, JE Bennett, R Doplin (eds). Churchill Livingstone international, New York, NY 1998.
Rosenblatt JD, Miles S, Gasson JC, Prager D. Transactivation of cellular genes by human retroviruses. In Transacting Functions of Human Retroviruses, Clinical Topics in Microbiology and Immunology. Chen ISY, Koprowski H, Srinivasan A, Vogt PK, eds. Springer Verlag, New York 1995.
Rosenblatt JD, Black AC: Human T-cell leukemia viruses: HTLV-2. In Encyclopedia of Virology, Webster RG (ed). Saunders Scientific Publications, W.B. Saunders Co., London, 1994, pp 686-695.
Rosenblatt, J.D. A Human Non-HIV retroviral infections;Editorial Comment in Infections in Medicine, 1994, 11:547.
Kampe CE, Harrington WB, Gill P, Black AC Saunders, Rosenblatt JD. Adult T-cell leukemia/lymphoma, Cancer Treatment, 4th ed., Saunders Haskell, C. Editor, 1994, Chapter 95.
Rosenblatt, JD. Human T-lymphotropic virus types I and II. Western Journal of Medicine, 1993, 158:379-384.
Black AC, Rosenblatt JD. Human T-cell leukemia virus infections. In: Infectious Diseases: A Treatise of Infectious Processes, fifth edition, JB Lippincott 1993.
Rosenblatt JD, Danon Y, Black AC: A decade with HTLV-I and HTLV-II: Lessons in viral leukemogenesis. Leukemia, 1992, 6:18-23.
Rosenblatt JD: Human Retrovirology: HTLV. In Cancer Cells, Blattner W (ed). ColdSpringHarbor Publications, Cold Spring Harbor, NY, 1991, 155-157.
Chen ISY, Rosenblatt JD: Human T-Cell Leukemia Virus Type II, in The Human Retroviruses, Gallo R, Jay G, eds. Academic Press, Inc., New York, 1991, 21-33.
Black AC, NimerSD, Chen ISY, Rosenblatt JD: The effects of Tax and Rex proteins of HTLV-I/-II on viral and cellular gene regulation. UCLA Symposium on Human Retroviruses, Groopman J, Chen ISY, Essex M, Weiss R, Eds. Alan R. Liss, New York, 1991.
Rosenblatt JD, Wachsman W, Chen ISY: Retroviruses and Leukemia: Recent Developments, in Leukemia: Recent Progress, Future Advances, UCLA Hyland Colloquium, Gale RP, Rai K, eds. Alan R. Liss, New York, 1991.
Cann AJ, Rosenblatt JD, Wachsman W, Chen ISY: Molecular biology and pathogenesis of HTLV-II. In Retrovirus Biology: An Emerging Role in Human Diseases, Gallo RC, Wong-Staal F, eds. Marcel Dekker, New York, 1991.
Panoskaltsis N, Rosenblatt JD. A Cell Therapy: Stem Cell Transplantation, Gene Therapy, and Cellular Immunotherapy: by George Mortsyn and William Sheridean. Editorial (Book Review) in Bulletin of the New YorkAcademy of Medicine: A Journal of Urban Health.
Black AC, Rosenblatt JD, Chen ISY: Viral Trans-activating Genes. In Genes and Cancer, Sikora K, Carney D (eds). John Wiley & Sons, West Sussex England, 1990, 137-150.
Rosenblatt JD, Zack JA, Chen ISY, Lee H: Recent advances in detection of HTLV-I and HTLV-II infection. J Nat Immun Cell Growth Regul, 1990, 9:143-149.
Chen ISY, Cann AJ, Lugo JP, Rosenblatt JD: Models for Mechanisms of Transformation by the Human T-cell Leukemia Viruses. In Retroviruses and Disease, PullmanME, Hanafusa H, Pinter A (eds). Academic Press, Inc., New York, 1989, 113-125.
Rosenblatt JD, Chen ISY, Golde DW: HTLV-II and human lymphoproliferative disorders. In Clinics in Laboratory Medicine, Yeager E, ed. Saunders, Philadelphia PA, Vol. 8, 1988, 85-95.
Rosenblatt JD, Chen ISY, Wachsman W: Infection with HTLV-I and HTLV-II: Evolving Concepts. Semin Hematol, 1988, 25:230-246.
Aboud M, Wachsman W, Rosenblatt JD, Cann AJ, Golde DW, Gaynor RB, Slamon DJ, Chen ISY: Biology and Leukemogenicity of human T-cell leukemia viruses. In Viruses and Human Cancer, UCLA Symposia on Molecular and Cellular Biology, Park City, UT, Vol 43, Gallo RC, Haseltine W, Klein G, zur Hausen H, eds. Alan R. Liss, New York, 1987, pp 109-129.
Cann AJ, Rosenblatt JD, Shah NP, Williams J, Wachsman W, Chen ISY: Expression of the human T-cell leukemia virus x gene in vitro. In Viruses and Human Cancer, UCLA Symposia on Molecular and Cellular Biology, Park City UT, Vol 43, Gallo RC, Haseltine W, Klein G, zur Hausen H, eds. Alan R. Liss, New York, 1987, 221-235.
Naeim F, Kemani-Arab V, Hoon D, Gatti D, Rosenblatt J, Concannon P: Immortalization of T-lymphocytes derived from Patients with Hairy Cell Leukemia of B-cell type. In Recent Advances in Leukemia and Lymphoma, Gale RP, Golde DW, eds. Alan R. Liss, New York, Vol 61, 1987.
Rosenblatt JD, Wachsman W, Chen ISY: Retroviruses and Leukemia: Recent Developments. In Chronic Lymphocytic Leukemia: Recent Progress and Future Directions, UCLA Hyland Colloquium, Gale RP, Rai K, eds. Alan R. Liss, New York, 1987, 11-28.
Rosenblatt JD, Cann AJ, Golde DW, Chen ISY: Structure and Function of the Human T-cell Leukemia Virus II genome. In Cancer Reviews, Vol. 1, Hinuma Y (ed.). Munksgaard, CopenhagenDenmark, 1986, 115-135.
Chen ISY, Wachsman W. Rosenblatt JD, Cann AJ: The role of x gene in HTLV-associated Malignancy. Cancer Surveys, 5, LondonEngland, 1986.
Rosenblatt J, Wachsman W, Shimotohno K, Slamon D, Chen ISY: The comparative molecular biology of HTLV-I and HTLV-II. In Retroviruses in Human Lymphoma/Leukemia, Miwa M, et al. (eds). Japan Scientific Society Press,Tokyo VnY Science Press, Utrecht, 1985, 177-185.
Juried or refereed journal articles and exhibitions:
Andela VB, Schwartz EM, Rosenblatt JD, Puzas EJ, O’Keefe RJ, Rosier RN. Genome-Wide Expression Profiling and System-Level Integration of Nuclear Factor Kappa B Regulated Genes in Malignant Progression, in press.
Cho HM, Rosenblatt JD, Kang, YS, Iruela-Arispe ML, Morrison SL, Penichet ML, Kwon YG, Kim TW, Webster KA, Nechustan H, Shin SU. Enhanced Inhibition of Murine Tumor and Human Breast Tumor Xenographfts Using Targeted Delivery of An Antibody-Endostatin Fusion Protein. Mol Cancer Therapy, June 2005, 4 (6): 956-67.
Shah S, Divekar AA, Hilchey SP, Cho HM, Newman CL, Shin Su, Nechustah H, Challita-Eid PM, Segal BM, Yi KH, Rosenblatt JD. Increased Rejection of Primary Tumors in Mice Lacking B Cells: Inhibition of Anti-Tumor CTL and T(H)1 cytokine responses by B cells. Int J Cancer, May 2005.
Heresi, Gustavo A., Wang, Jingchen, Taichman, Russell, Chirinios, Julio A., Regalado, Jacinto J., Lichtstein, Daniel M., Rosenblatt, Joseph D. Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: Report of a case, review of the literature, and analysis of chemokine receptor expression. Urologic Oncology: Seminars and original Investigations 23, 2005, pp 261-267.
Morgensztern D, Rosado MF, Silva O, Santos ES, Abdullah SA, Goodman M, Hamilton-Nelson K, Rosenblatt JD, Lossos I. Prevalence of Hepatitis C Infection in Patients with Non-Hodgkin’l Lymphoma in South Florida and Review of Literature. Leukemia & Lymphoma, December 2004, Vol 45 (12), pp 2459-2464.
Ciardella M, Tran L, O’Dorisio T, Chazot FB, Oberg K, Lowell A, Baudin E, Van Cutsem E, Baulieu JL, LeGuludec D, McCance D, Caplin M, Rosenblatt, JD, Grossman A, Hicks R, Modin I, Buxton-Thomas M, Le Cloirec J, Benson A, Turner H. A Phase II Open-LabelMulti-Center Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Patients with Symptomatic Malignant Carcinoid Tumors. November 2004. Submitted
Looney RJ, Anolik JH, Campbell D, Felgar RE, Young F, Arend LJ, Sloand JA, Rosenblatt JD, and Sanz I. BCell Depletion as a Novel Treatment of Systemic Lupus Erythematosus: A Phase I/II Dose-Escalation Trial of Ritusimab, Arthritis & Rheumatism, August 2004,
pp 2580-2589.
Pandya KJ, Thummala A, Griggs JJ, Rosenblatt JD, Sahasrabudhe DM, Guttuso TJ, Morrow GR, Roscoe JA. Pilot Study Using Gabapentin for Tamoxifen-Induced Hot Flashes in Women with Breast Cancer. Breast Cancer Research and Treatment 83:87-89, 2004.
Cho HM, Rosenblatt JD, Kang YS, Iruela-Arispe JL, Morrison SL, Kwon YG, Kim TW, Webster KA, Shin S. Enhanced Inhibition of Tumor Growth using Targeted Delivery of an Antibody-Endostatin Fusion Protein. Cancer Research, June 2004. In press
Santos ES, Rosenblatt JD, Goodman M. The Role of Farnesyltransferanse Inhibitors in Acute Leukemia. Expert Rev Anticancer Therapy, May 2004, pp 843-856.
Amado RG, Mitsuyasu RT, Rosenblatt, JD, Ngok FK, Bakker A, Cole S, Chorn N, Lin LS, Bristol G, Boyd MP, MacPherson JL, Fanning GC, Todd AV, Ely JA, Zack JA, Symonds GP. Anti-Human Immunodeficiency Virus Hematopoietic Progenitor Cell-Delivered Ribozyme in a Phase I Study: Myeloid and Lymphoid Reconstitution in Human Immunodeficiency Virus Type-I Infected Patients. Human Gene Therapy 15:251-262, March 2004.
Liesveld JL, Lancet JD, Rosell KE, Menon A, Lu C, McNair C, Abboud CN, Rosenblatt JD. Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis. Leukemia 17, 1806-1812, 2003.
Anolik JH, Campbell D, Felgar RE, Young F, Sanz I, Rosenblatt JD, Looney RJ. The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheum. February 2003, 48(2), pp 455-9.
Tolba KA, Bowers WJ, Eling DJ, Casey AE, Kipps TJ, Federoff HJ, Rosenblatt JD. HSV amplicon-mediated delivery of LIGHT, enhances the antigen-presenting capacity of chronic lymphocytic leukemia. Molecular Therapy. Vol 6, No. 4, October 2002.
Tolba KA, Bowers WJ, Muller J, Housekneckt V, Giuliano RE, Federoff HJ, Rosenblatt JD.
HSV amplicon-mediated co-delivery of secondary lymphoid tissue chemokine (SLC) and CD40L results in augmented anti-tumor activity. Cancer Research, June 2002.
Andela VB, Rosenblatt JD, Schwarz EM, Puzas EJ, O’Keefe RJ, Rosier RN. Synergism of Aminobisphosphonates and Farnesyl Transferase Inhibitors on Tumor Metastasis. Clinical Orthopaedics & Related Research, Vol 397; 228-239, April 2002.
Andela VB, Souza MD, Schwarz EM, O’Keefe RJ, Puzas EJ, Rosenblatt, JD, Rosier RN. Mutual Antagonism between NFkB and Retinoic Acid Receptors: Implications in Malignant Progression and Regression. Submitted.
Chen Y, Pandya K, Keng PP, Feins R, Raubertas R, Smudzin T, Rosenblatt J, Okunieff P. Schedule-Dependent Pulsed Paclitaxel Radiosensitization for Thoracic Malignancy. Am J Clin Oncol 24(5): 432-437, 2001.
Belly RT, Rosenblatt JD, Steinmann M, Toner J, Sun J, Shehadi J, Peacock J, Raubertas RF, Jani N, Ryan CK. Detection of Mutated K-12 ras in Historically Negative Lymph Nodes as an Indicator of Poor Prognosis in Stage II Colorectal Cancer. Clinical Colorectal Cancer, No. 2, 1:110-116, August, 2001.
Renda MJ, Rosenblatt JD, Klimatcheva E, Demeter L, Bambara, R, Planelles, V. Mutation
of the Methylated tRNALys3 Residue A58 Disrupts Reverse Transcription and Inhibitors Replication of the Human Immunodeficiency Virus, Type 1, J Virol, Oct, 2001, Vol 75, 20:9671-9678.
Klimatcheva E, Planelles V, Day S, Fulreader F, Renda MJ, Rosenblatt J. Defective Lentiviral Vectors are Efficiently Trafficked by HIV-1 and Inhibit its Replication. Molecular Therapy, June, 2001, 3:928-939.
Penichet ML, Dela Cruz JS, Challita-Eid PM, Rosenblatt JD and Morrison SL. A murine B cell lymphoma expressing human HER2/neu undergoes spontaneous tumor regression and elicits anti-tumor immunity. Cancer Immunology Immunotherapy, 2001, 49:649-662.
Tolba, K.A., Bowers Wm. J., Hilchey, S.P., Halterman, M.W., Howard, D.F., Giuliano, R.E., Federoff, H.J., Rosenblatt, J.D. Development of HSV-1 Amplicon-based Immunotherapy for Chronic Lymphocytic Leukemia. Blood, July, 2001, 98:287-295.
Karp J, Lancet J., Kaufman S., End D., Wright J.J., Horank I., Tidwell, M., Liesveld J., Ange D., Buddharaju L., Gojo I., Highsmith W.E., Rybak M.E., Rosenblatt J. Phase I Clinical trial of R115777 in Adults with Acute Leukemia. Blood, June, 2001, 97:3361-3369.
Ifthikharuddin, JJ, Mieles, LA, Rosenblatt, JD, Ryan, CK, Sahasrabudhe, DM. CD-20 expression in post-transplant lymphoproliferative disorders: Treatment with Rituximab. American Journal of Hematology, October, 2000, 65:171-173.
Mahmood K, Federoff HJ, Challita-Eid PM, Day B, Haltman M, Atkinson M, Planelles V, and Rosenblatt JD. Eradication of pre-established lymphoma using HSV amplicon vectors. Blood, 1999, 93:643-654.
Amado RG, Mitsuyasu RT, Symonds G, Rosenblatt JD, Zack J, Sun LQ, Miller M, Ely J. Gerlach W. A Phase I trial of Autologous CD34+ Hematopoietic Progenitor Cells Transduced With An Anti-HIV Ribozyme. Human Gene Therapy, September, 1999, 1;10 (13):2255-70.
Shostak LD, Ludlow J, Fisk J, Pursell S, Rimel BJ, Nguyen D, Rosenblatt JD, Planelles V. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1-vpr. Experimental Cell Research, August, 1999, 251:156-165.
Penichet Manuel L, Challita-Eid PM, Shin Seung-Uon, Sampogna SL, Rosenblatt JD, Morrison SL. In vivo properties of three human HER2/neu expressing murine cell lines in immunocompetent mice. Laboratory Animals Science, April 1999, 49:179-188.
Challita P, Penichet M, Shin S, Mosammaparast N, Ples T, Mahmood K, Slamon D, Morrison S, Rosenblatt J. A B7.1-Antibody Fusion Protein Retains Antibody Specificity and Ability to Activate via the T Cell Costimulatory Pathway. J Immunol, 1998, 160:3419-3416.
Challita PM, Abboud CN, Morrison SL, Penichet M,Rosell K, Rosenblatt JD: A RANTES-antibody fusion protein retains antigen specificity and chemokine function. J Immunology, 1998, 161:3729-3736.
Amado RG, Symonds G, Jamieson BD, Zhao G, Rosenblatt JD, Zack JA: Effects of Megakaryocytic Growth and Development Factor on survival and retroviral transduction of T-lymphoid progenitor cells. Human Gene Therapy, 1998, 9:173-183.
Challita-Eid PM, Klimacheva E, Day BT, Evans T, Dreyer K, Rimel BJ, Rosenblatt JD and Planelles V. Inhibition of HIV Type 1 infection with a RANTES-IgG3 fusion protein. Aids Res. Hum. Retro., No. 18, 1998, 14:1617-1624.
Lu Y, Planelles V, Li X, Palaniappan C, Day B, Challita-Eid P, Amado R, Stephens D, Kohn DB, Bakker A, Fay P, Bambara R, Rosenblatt JD, Inhibition of HIV-I replication using a mutated tRNALYS3 primer. J. Bio. Chem., 1997, 272:14523-14531.
Ferreira O, Planelles V, Rosenblatt J. Human T-Cell Leukemia Viruses: Epidemiology, Biology, and Pathogenesis. Blood Reviews, 1997, 11:91-104.
Bakker A, Li X, Ruland CT, Stephens DW, Black AC, Rosenblatt JD. Human T-Cell Leukemia Virus Type 2 Rex Inhibits pre-mRNA Splicing In Vitro at an Early Stage of Spliceosome Formation. J Virol., 1996, 70:5511-5518.
Watanabe CT, Rosenblatt JD, Bakker A, Morgan JP, Luo J, Chun S, Black AC. Negative regulation of gene expression from the HTLV Type II Long Terminal Repeat by Rex: Functional and structural dissociation from positive post-transcriptional regulation. AIDS Research and Human Retroviruses, 1996, 12(6):535-546.
Black AC, Luo J, Chun S, Bakker A, Fraser JK, Rosenblatt, JD. Specific Binding of Polypyrimidine Tract Binding Protein and hnRNP A1 to HIV-1 CRS Elements. Virus Genes, 1996, 12:3, 275-285.
Woodruff KA, Rosenblatt JD, Morre TB, Medzoyan RH, Pai DSM, Noland JL, Yamashiro JM, Wada RK. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer. Oncogene, 1995, 10:1335-1341.
Black AC, JK, Luo J, Watanabe C, Chun S, Bakker A, Fraser JK, Morgan JP, Rosenblatt JD. Polypyrimidine Tract-binding Protein and Heterogeneous Nuclear Ribonucleoprotein Al bind to Human T-Cell Leukemia Virus Type II RNA Regulatory Elements. J Virology, 1995, 69:6852-6858.
Ejima J, Rosenblatt JD, Ou J, Prager D. Parathyroid hormone related protein gene expression and human T-cell leukemia virus-1 infection. Miner Electrolyte Metab, 1995, 21:143-147.
Ucar K, Seeger RC, Challita PM, Watanabe CT, Yen TL, Morgan JP, Amado R, Chou E, McCallister T. Barber JR, Jolly DJ, Reynolds CP, Gangavalli R, Rosenblatt JD. Sustained Cytokine production and immunophenotypic changes in human neuroblastoma cell lines transduced with a human gamma interferon vector. Cancer Gene Therapy, 1995, 2:171-181.
Tsien, A, Rosenblatt J, Schanker, H. Facial edema in a woman with a history of histiocytosis X. Annals of Allergy, Asthma and Immunology, 1995, 74:223-227.
Philip R, Brunette E, Kilinski L, Murugesh D, McNally MA, Ucar K, Rosenblatt JD, Okarma TB, Lebkowski JS. Efficient and sustained gene expression in primary T-lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol. Cell. Bio., 1994, 14:2411-2418.
Black AC, Ruland CT, Luo J, Fraser JK, Rosenblatt JD. Binding of nuclear proteins to HTLV-II cis-acting repressive sequence (CRS) RNA correlates with CRS function. Virology, 1994, 200:29-41.
Saven A, Figueroa ML, Piro, LD, Rosenblatt JD. 2-chlorodeoxyadenosine-induced complete remission in refractory histiocytosis. New Engl J Med, 1994, 329:734-735.
Akkina RK, Rosenblatt JD, Campbell A, Chen ISY, Zack J. Modeling human lymphoid precursor cell gene therapy in the SCID/hu mouse. Blood, 1994, 84:1392-1398.
Prager D, Rosenblatt JD, Ejima E. Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection. Leukemia/Lymphoma, 1994, 14:395-400.
Kilim Y, Rosenblatt JD, Danon YL. Sequence analysis of the new human T-cell leukemia/lymphoma virus type I isolate (HTLV-1) in Israel. Isr J Med Sci, 1994, 39:891-894.
Kilim Y, Rosenblatt JD, Danon YL. Molecular characterization of HTLV-I infection in Israel. J NY Acad Sci, 1994, 724:417-421.
Ejima E, Rosenblatt JD, Massari M, Quan E, Stephens D, Rosen CA, Prager D. Cell-type-specific transactivation of the parathryoid hormone-related protein gene promoter by the HTLV-I Tax and HTLV-II Tax proteins. Blood, 1993, 81:1017-1024.
Feuer G, Zack JA, Harrington WJ, Valderama R, Jr., Rosenblatt JD, Wachsman W, Baird SM, Chen ISY. Establishment of human T-cell leukemia virus type I T-cell lymphomas in Severe Combined Immunodeficient mice. Blood, 1993, 82:722-731.
Lee H, Idler KB, Swanson P, Aparicio JJ, Chen KK, Lax JP, Nguyen M, Mann T, Leckie G, Zenetti A, Marinucci G, Chen ISY, Rosenblatt JD. Complete nucleotide sequence of HTLV-II isolate NRA: comparison of envelope sequence variation of HTLV-II isolates from US blood donors and US and Italian IV drug users. Virology, 1993, 196:57-69.
Miller AR, McBride WH, Dubinett SM, Dougherty GJ, Thacker JD, Shau H, Kohn DB, Moe RC, Walker MJ, Chiu R, Schuck BL, Rosenblatt JD, Rhoades K, Economou JS. Transduction of human melanoma cell lines with the human IL-7 gene using retroviral-mediated gene transfer: comparison of immunological properties with IL-2. Blood, 1993, 82:3686-3694.
Wada RK, Seeger RC, Reynolds M, Kacena A, Chan G, Valderama R, Harrington W, Jr., Saxton E, Diagne A, Zhao J-Q, Mitsuyasu RT, Weisbart RH: Progressive spastic myelopathy in a patient co-infected with HIV-1 and HTLV-II: Autoantibodies to the human homologue of rig in blood and cerebrospinal fluid. AIDs, 1992, 6:1151-1158.
Sakamoto KM, Nimer SD, Rosenblatt JD, Gasson JC. HTLV-I and HTLV-II tax trans-activated the human EGR-1 promoter through different cis-acting sequences. 1992, Oncogene, 1992, 7:2125-2130.
Weisbart RH, Wong AL, Noritake D, Kacena A, Chan G, Chin E, Chen ISY, Ruland C, Rosenblatt JD: The rheumatoid factor activity of a human IgG monoclonal autoantibody is encoded by a variant V “kappa” II light chain. J Immunol, 1991, 147:2795-2801.
Black AC, Arrigo SJ, Ruland CT, Allogiamento T, Chin E, Chen ISY, Rosenblatt JD: Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5-lung terminal repeat. Virology, 1991, 181:433-444.
YipMT, Dynan WS, Green PL, Black AC, Arrigo SJ, Torbati A, Heaphy S, Ruland C, Rosenblatt JD, Chen ISY: HTLV-II Rex protein binds specifically to RNA sequences of the HTLV LTR but poorly to the HIV-1 RRE. J Virol, 1991, 65:1161-1172.